cmAngio® vs DeepTek CXR Analyzer
AI Verdict
Choose cmAngio® if…
Choose cmAngio® if your primary objective is to utilize existing mammography data for early cardiovascular risk assessment in women. This AI software is specifically designed to detect Breast Arterial Calcifications (BAC) on mammograms, providing crucial insights into cardiovascular health without requiring additional radiation or procedures. It is ideal for integrating cardiac risk screening into breast imaging workflows.
View cmAngio® →Choose DeepTek CXR Analyzer if…
Choose DeepTek CXR Analyzer if you require a comprehensive AI-powered CADe solution to enhance the efficiency and accuracy of chest X-ray interpretation across a broad spectrum of pathologies. This tool automatically detects and highlights suspicious regions related to lung, pleural, and cardiac conditions, significantly reducing radiologist workload and boosting productivity. It is best suited for departments seeking to streamline and automate the analysis of diverse chest X-ray findings.
View DeepTek CXR Analyzer →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | cmAngio® | DeepTek CXR Analyzer |
|---|---|---|
| Pricing | Paid, out-of-pocket | Global access pricing available for eligible public sector and not-for-profit healthcare providers in 138 low- and middle-income countries, offering unlimited ai analyses per connected x-ray unit, installation, user training, product updates, maintenance, and technical support via an annual subscription. |
| Deployment | Cloud-based, integrates with any DICOM-compliant viewer | On-premise and Cloud offerings. The solution supports online, offline, and hybrid deployment. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
DeepTek CXR AnalyzerBoth tools emphasize ease of integration. Tool B offers both cloud and on-premise deployment options, providing greater flexibility for diverse IT environments. Additionally, its output is a secondary capture DICOM with AI findings for easy interpretation, streamlining the radiologist's workflow directly within their existing PACS system.
Clinical Value
DeepTek CXR AnalyzerTool B provides a broader clinical application by detecting 28 findings across lung, pleural, cardiac pathologies, and hardware on chest X-rays, a highly common imaging modality. It directly claims to reduce radiologist workload by 30-50% and boost productivity by 2x-3%, with studies showing it outperformed unaided human readers in detecting suspicious ROIs. Tool A focuses on a more niche, albeit important, application of detecting Breast Arterial Calcifications for cardiovascular risk assessment.
Pricing & Value
DeepTek CXR AnalyzerTool B explicitly offers a 'Pay-per-use' pricing model, which provides greater transparency and flexibility for cost management and scalability. While Tool A mentions potential limited-time offers for no-cost implementation, its general pricing is not publicly available, making it harder to assess long-term value.
Enterprise Readiness
DeepTek CXR AnalyzerBoth tools are FDA-cleared and HIPAA-compliant. However, Tool B explicitly states it has a Business Associate Agreement (BAA) in place and offers both cloud and on-premise deployment options. This dual deployment capability provides greater flexibility to meet diverse enterprise IT infrastructure and security requirements, making it more adaptable for various healthcare organizations.
Innovation
cmAngio®Tool A demonstrates higher innovation by leveraging existing mammography data to detect Breast Arterial Calcifications (BAC) for cardiovascular risk assessment, a novel application that extends the utility of routine breast screening beyond cancer detection. This approach provides new clinical insights from an established imaging modality.
Support & Docs
DeepTek CXR AnalyzerTool B provides more explicit details regarding its support infrastructure, including a dedicated customer support email and phone number, a 'Resources Hub' with white papers, and an 'Installation Guide'. Its FDA submission also references a user manual, and a job description for a Technical Support Engineer outlines comprehensive support responsibilities including training. Tool A mentions contact support and an operator's manual, but with less detail.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | cmAngio® | DeepTek CXR Analyzer |
|---|---|---|
| Tool Name | cmAngiou00ae | DeepTek CXR Analyzer |
| Company | CureMetrix | DeepTek Medical Imaging Pvt |
| Description | FDA-cleared AI software for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment. | FDA-cleared AI-powered CADe solution for chest X-ray analysis, designed to assist radiologists by automatically detecting and highlighting suspicious regions across lung, pleural, and cardiac pathologies, significantly improving workflow efficiency and diagnostic accuracy. |
| Primary Focus | Breast Arterial Calcifications (BAC) detection on mammograms | Chest X-ray analysis for lung, pleural, and cardiac pathologies |
| Key Features | AI-based detection of Breast Arterial Calcifications (BAC); Processes both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams; Provides visualization of BAC location on a scorecard; Enables BAC identification and reporting without additional radiation or procedures; Compatible with any DICOM-compliant viewer; Adjustable operating point to meet clinical goals; Quick and easy installation (less than an hour); Cybersecure and HIPAA-compliant | AI-Powered Computer-Assisted Detection (CADe) for Chest X-rays; Detection of 28 findings covering lung, pleural, cardiac pathologies, and hardware; Automatic identification, categorization, and highlighting of suspicious regions of interest (ROIs); Seamless DICOM-based PACS integration (on-premise or cloud); Intelligent segregation of scans into 'AI Finding-Negative' and 'AI Finding-Positive'; Reduces radiologist workload by 30-50% and boosts productivity by 2x-3x; Generates secondary capture DICOM with AI output for easy interpretation; Compatible with various X-ray modalities (hospital, mobile, portable, handheld) |
Videos
Demos, reviews, and walkthroughs featuring cmAngio® and DeepTek CXR Analyzer.